Fulvestrant

Fulvestrant

Pls contact:Crystal(at)health-gym(dot)com

skype:healthclub66

CAS:129453-61-8

Purity:99%

Appearance:white powder

Synonyms: FASLODEX

Chemical Name:(7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol

Molecular Fomular:C32H47F5O3S

Molecular Weight:606.77

Density:1.201 g/cm3

Melting Point:104-106°C

Boiling Point:674.8 °C at 760 mmHg

Package:10g/foil bag

Usage:Antineoplastic (hormonal)

Applications :

Many breast cancers are stimulated to grow by the female sex hormones oestrogen and progesterone. These breast cancers are called hormone sensitive or hormone receptor positive. Drugs that block the effects of these hormones can slow or stop the growth of the breast cancer cells. Fulvestrant stops oestrogen getting to the cancer cells by blocking oestrogen receptors and reducing the number of receptors the cancer cell has.

Fulvestrant (Faslodex, AstraZeneca) is a drug treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. It is an estrogen receptor antagonist with no agonist effects, which works by down-regulating the estrogen receptor.

Fulvestrant is a selective estrogen receptor down-regulator (SERD). Fulvestrant is indicated for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. The dosing schedule for fulvestrant remains under investigation in an attempt to optimize its effectiveness.